SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

74,294.96 -19.63
( -0.03%)

Global Indices

Nasdaq

51,699.28 -99.76
(-0.19%)

Dow Jones

7,668.45 9.69
(0.13%)

Hang Seng

65,040.24 903.99
(1.41%)

Nikkei 225

10,654.81 -161.33
(-1.49%)

Forex

USD-INR

95.87 0.21
(0.22%)

EUR-INR

110.00 -0.22
(-0.20%)

GBP-INR

128.18 -0.44
(-0.35%)

JPY-INR

0.61 0.00
(-0.09%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Wanbury Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524212

INE107F01022

41.3185648

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

WANBURY

13.15

780.29

EPS(TTM)

Face Value()

Div & Yield %

16.97

Particulars(INCOME)	Mar 2026 ( Cr)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)
Sales Turnover	650.27	599.51	577.74	499.65	511.19	392.52
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	650.27	599.51	577.74	499.65	511.19	392.52
Other Income	0.94	3.49	0.90	0.91	77.88	2.40
Stock Adjustments	13.00	-1.51	3.89	-29.13	24.79	7.20
Total Income	664.21	601.49	582.53	471.43	613.86	402.12
EXPENDITURE :
Raw Materials	289.51	292.96	307.48	274.31	325.07	228.53
Power & Fuel Cost	28.59	24.24	25.17	20.59	18.41	17.13
Employee Cost	119.64	101.56	86.92	81.00	74.81	64.15
Other Manufacturing Expenses	13.63	13.76	13.32	11.43	12.66	9.98
Selling & Administrative Expenses	75.68	65.92	58.71	45.16	55.34	45.49
Miscellaneous Expenses	33.07	23.15	17.93	15.45	14.36	16.42
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	560.12	521.58	509.54	447.94	500.65	381.70
Operating Profit	104.10	79.91	72.99	23.49	113.19	20.42
Interest	29.98	36.95	29.18	21.39	20.61	23.07
Gross Profit	74.12	42.96	43.81	2.10	92.58	-2.65
Depreciation	14.31	13.41	13.03	12.38	11.45	9.75
Profit Before Tax	59.81	29.55	30.78	-10.28	81.13	-12.40
Tax	0.65	5.86	0.00	0.00	0.00	2.27
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-6.98	-6.84	0.38	0.11	-0.35	-2.07
Reported Net Profit	66.13	30.53	30.40	-10.40	81.47	-12.61
Extraordinary Items	-3.53	2.05	0.49	-0.31	76.06	1.21
Adjusted Net Profit	69.66	28.48	29.91	-10.09	5.41	-13.82
Adjustment below Net Profit	-0.56	-0.38	-0.59	0.26	0.80	-0.44
P & L Balance brought forward	-108.17	-138.34	-168.14	-158.01	-240.28	-227.23
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance carried down	-42.60	-108.19	-138.34	-168.14	-158.01	-240.28
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	18.93	9.32	9.28	-3.18	24.94	-5.04
Earnings Per Share(Adj)-Unit Curr	18.93	9.32	9.28	-3.18	24.94	-5.04
Book Value-Unit Curr	41.34	16.26	6.70	-2.26	0.57	-52.23
Book Value(Adj)-Unit Curr	41.34	16.26	6.70	-2.26	0.57	-52.23

74,294.96 -19.63 ( -0.03%)

51,699.28 -99.76 (-0.19%)

7,668.45 9.69 (0.13%)

65,040.24 903.99 (1.41%)

10,654.81 -161.33 (-1.49%)

95.87 0.21 (0.22%)

110.00 -0.22 (-0.20%)

128.18 -0.44 (-0.35%)

0.61 0.00 (-0.09%)